Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.52 - $1.05 $534 - $1,078
-1,027 Reduced 7.97%
11,861 $10,000
Q3 2023

Nov 15, 2023

SELL
$1.67 - $3.33 $15,390 - $30,689
-9,216 Reduced 41.69%
12,888 $21,000
Q2 2023

Aug 11, 2023

BUY
$2.83 - $4.94 $12,268 - $21,414
4,335 Added 24.4%
22,104 $62,000
Q4 2022

Aug 11, 2023

SELL
$8.88 - $12.77 $4,564 - $6,563
-514 Reduced 2.81%
17,769 $190,000
Q4 2022

Feb 13, 2023

SELL
$8.88 - $12.77 $4,564 - $6,563
-514 Reduced 2.81%
17,769 $190,000
Q3 2022

Aug 11, 2023

SELL
$8.24 - $12.56 $4,045 - $6,166
-491 Reduced 2.62%
18,283 $171,000
Q3 2022

Nov 03, 2022

SELL
$8.24 - $12.56 $4,045 - $6,166
-491 Reduced 2.62%
18,283 $171,000
Q2 2022

Aug 11, 2023

SELL
$7.45 - $13.84 $2,875 - $5,342
-386 Reduced 2.01%
18,774 $171,000
Q2 2022

Aug 15, 2022

SELL
$7.45 - $13.84 $2,875 - $5,342
-386 Reduced 2.01%
18,774 $171,000
Q1 2022

Aug 11, 2023

BUY
$9.94 - $12.65 $13,826 - $17,596
1,391 Added 7.83%
19,160 $232,000
Q1 2022

May 20, 2022

SELL
$9.94 - $12.65 $49,163 - $62,566
-4,946 Reduced 20.52%
19,160 $233,000
Q4 2021

Feb 16, 2022

BUY
$11.99 - $18.14 $3,920 - $5,931
327 Added 1.38%
24,106 $294,000
Q3 2021

Nov 12, 2021

SELL
$11.55 - $16.06 $25,132 - $34,946
-2,176 Reduced 8.38%
23,779 $367,000
Q2 2021

Aug 12, 2021

BUY
$12.38 - $29.19 $22,964 - $54,147
1,855 Added 7.7%
25,955 $370,000
Q1 2021

May 03, 2021

SELL
$15.07 - $21.71 $22,107 - $31,848
-1,467 Reduced 5.74%
24,100 $523,000
Q4 2020

Feb 12, 2021

BUY
$12.72 - $16.16 $9,921 - $12,604
780 Added 3.15%
25,567 $387,000
Q2 2020

Aug 10, 2020

SELL
$12.39 - $17.33 $12,637 - $17,676
-1,020 Reduced 3.95%
24,787 $416,000
Q1 2020

May 15, 2020

BUY
$9.12 - $17.78 $15,750 - $30,706
1,727 Added 7.17%
25,807 $341,000
Q4 2019

Feb 14, 2020

BUY
$16.11 - $25.98 $3,640 - $5,871
226 Added 0.95%
24,080 $388,000
Q3 2019

Nov 12, 2019

BUY
$18.28 - $26.91 $41,733 - $61,435
2,283 Added 10.58%
23,854 $445,000
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $166,969 - $203,707
9,444 Added 77.88%
21,571 $464,000
Q1 2019

May 13, 2019

BUY
$14.41 - $19.64 $23,661 - $32,248
1,642 Added 15.66%
12,127 $238,000
Q4 2018

Feb 14, 2019

SELL
$12.45 - $23.47 $140,510 - $264,882
-11,286 Reduced 51.84%
10,485 $136,000
Q3 2018

Nov 14, 2018

BUY
$17.57 - $23.95 $6,430 - $8,765
366 Added 1.71%
21,771 $522,000
Q2 2018

Aug 14, 2018

BUY
$11.6 - $19.27 $1,322 - $2,196
114 Added 0.54%
21,405 $410,000
Q1 2018

May 15, 2018

SELL
$11.77 - $16.08 $4,990 - $6,817
-424 Reduced 1.95%
21,291 $264,000
Q4 2017

Feb 08, 2018

BUY
$11.86 - $14.08 $6,748 - $8,011
569 Added 2.69%
21,715 $266,000
Q3 2017

Nov 14, 2017

BUY
$12.6 - $16.34 $266,439 - $345,525
21,146
21,146 $290,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14.5M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.